24-Month Clinical results for Healionics’ STARgraft featured at CiDA conference
SEATTLE, WA, UNITED STATES, November 3, 2025 /EINPresswire.com/ -- Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced the presentation of 24-month clinical results for its STARgraft arteriovenous ( …